Pharmadule Morimatsu wins European design order for a modular F&F facility

Nacka, Stockholm: – Pharmadule Morimatsu AB the Swedish-based world-wide turnkey supplier specialist in modular construction, facility engineering and process equipment for the pharma and biotech industries, has received an order from a highly recognized global Pharmaceutical company to execute a Conceptual Design study for a new greenfield fill & finish facility project in MEA region.

The study will involve engineering departments from Pharmadule’s Stockholm offices and will be completed during beginning of 3rd quarter of 2018. The scope of delivery includes Process, Facility, Quality and Regulatory disciplines.

Modular solutions

This latest project forms further proof of the global attractiveness of Pharmadule Morimatsu modular facility and process solutions and engineering services approach. The company won this order against competition from other International and well recognized engineering and equipment providers.

About Pharmadule Morimatsu

Pharmadule Morimatsu designs and builds turnkey production facilities and process equipment’s for the pharma – biopharma Industries and also for the FMCG area (Fast Moving Consumer Goods). Pharmadule services extend from conceptual design to IQOQ qualifications completion, offering a one-stop-shop suite of services that include: Front-End Design & Pre-Engineering, Detailed Design, Fabrication, Quality Assurance (QA) and Validation Management.

The company was founded in September 1986 by engineer Clas Wallenborg whose vision was to use the same basic modular design techniques and technology used to build specialized spaces for offshore oil platforms to be able to deliver ‘ready-made’ hygienic pharmaceutical production and laboratory facilities worldwide. These could be designed and fabricated centrally under hi-tech controlled conditions and transported to pharma sites all over the world for final assembly and erection.

Since then, Pharmadule has successfully delivered more than 70 production facilities worldwide for clients including Eli Lilly, Merck, Baxter, GlaxoSmithKline, Genentech, Pfizer, AstraZeneca, forging The Pharmadule Way as a way of offering unique value and reassurance to customers, with off-site construction and modular design concepts to provide very high predictability of on time, on budget delivery and consistent high quality, regardless of final location.

Since 2011, Pharmadule has been part of the Morimatsu Group of Japan, which specializes in process equipment, forming Pharmadule Morimatsu AB, headquartered in Stockholm, Sweden. The company also has a strong presence in Asia with engineering and manufacturing facilities in Shanghai, providing an enhanced service for clients in new markets.